1 Gergianaki I, "Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus" 32 : 188-205, 2018
2 Lewis MJ, "The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus" 56 : i67-i77, 2017
3 Nozari N, "Systemic lupus erythematosus presenting with a fatal intestinal vasculitis : a case report" 6 : 162-164, 2014
4 Abdulla MC, "Spontaneous soft tissue haemorrhage in systemic lupus erythematosus" 68 : 199-202, 2016
5 Chida Y, "Spontaneous mediastinal haematoma" 2016 : bcr2016217799-, 2016
6 Libra F, "Spontaneous bleeding in systemic lupus erythematosus : endovascular treatment of two rare cases" 15 : 992-998, 2020
7 Abdulla MC, "SLE presenting as multiple hemorrhagic complications" 24 : 1103-1106, 2015
8 Cohen H, "Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial" 3 : e426-e436, 2016
9 Lalani TA, "Imaging findings in systemic lupus erythematosus" 24 : 1069-1086, 2004
10 Tian XP, "Gastrointestinal involvement in systemic lupus erythematosus: insight into pathogenesis, diagnosis and treatment" 16 : 2971-2977, 2010
1 Gergianaki I, "Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus" 32 : 188-205, 2018
2 Lewis MJ, "The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus" 56 : i67-i77, 2017
3 Nozari N, "Systemic lupus erythematosus presenting with a fatal intestinal vasculitis : a case report" 6 : 162-164, 2014
4 Abdulla MC, "Spontaneous soft tissue haemorrhage in systemic lupus erythematosus" 68 : 199-202, 2016
5 Chida Y, "Spontaneous mediastinal haematoma" 2016 : bcr2016217799-, 2016
6 Libra F, "Spontaneous bleeding in systemic lupus erythematosus : endovascular treatment of two rare cases" 15 : 992-998, 2020
7 Abdulla MC, "SLE presenting as multiple hemorrhagic complications" 24 : 1103-1106, 2015
8 Cohen H, "Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial" 3 : e426-e436, 2016
9 Lalani TA, "Imaging findings in systemic lupus erythematosus" 24 : 1069-1086, 2004
10 Tian XP, "Gastrointestinal involvement in systemic lupus erythematosus: insight into pathogenesis, diagnosis and treatment" 16 : 2971-2977, 2010
11 Ruiz-Irastorza G, "Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies" 20 : 206-218, 2011
12 Andreoli L, "Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature" 65 : 1869-1873, 2013
13 Alves SC, "Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus : case series and literature review" 25 : 1509-1519, 2016
14 성상석 ; 정청일, "A Case of Spontaneous Hemoperitoneum Presenting as the Initial Manifestation of Systemic Lupus Erythematosus" 대한내과학회 25 (25): 458-460, 2010
15 Erkan D, "14th International Congress on Antiphospholipid Antibodies : task force report on antiphospholipid syndrome treatment trends" 13 : 685-696, 2014